Marine Andreani

416 total citations
11 papers, 291 citations indexed

About

Marine Andreani is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Marine Andreani has authored 11 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Marine Andreani's work include Renal Diseases and Glomerulopathies (5 papers), Autoimmune Bullous Skin Diseases (3 papers) and Renal cell carcinoma treatment (2 papers). Marine Andreani is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Autoimmune Bullous Skin Diseases (3 papers) and Renal cell carcinoma treatment (2 papers). Marine Andreani collaborates with scholars based in France and United States. Marine Andreani's co-authors include Vincent Esnault, Barbara Seitz‐Polski, Sylvia Benzaken, Ghislaine Bernard, Sonia Boyer‐Suavet, Vesna Brglez, Patrick H. Nachman, Marion Crémoni, Christelle Zaghrini and Karine Dahan and has published in prestigious journals such as Frontiers in Immunology, Clinical Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Marine Andreani

11 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marine Andreani France 7 220 112 107 56 38 11 291
Nadia Dallera Italy 7 315 1.4× 135 1.2× 113 1.1× 36 0.6× 76 2.0× 16 370
Jessica Serafinelli Italy 9 144 0.7× 63 0.6× 37 0.3× 80 1.4× 49 1.3× 13 227
Alexandra Cambier France 9 215 1.0× 75 0.7× 36 0.3× 64 1.1× 34 0.9× 19 244
Marina Foramitti Italy 8 169 0.8× 44 0.4× 25 0.2× 58 1.0× 9 0.2× 9 242
F. Willis United Kingdom 5 113 0.5× 35 0.3× 116 1.1× 88 1.6× 33 0.9× 7 318
Durga Kanigicherla United Kingdom 9 371 1.7× 162 1.4× 191 1.8× 51 0.9× 30 0.8× 27 407
Maud Dehennault France 6 241 1.1× 110 1.0× 34 0.3× 59 1.1× 92 2.4× 10 295
Takeshi Yanagihara Japan 11 208 0.9× 55 0.5× 54 0.5× 74 1.3× 7 0.2× 20 312
Joseph Rivalan France 8 101 0.5× 43 0.4× 58 0.5× 28 0.5× 25 0.7× 13 222
Smaragdi Marinaki Greece 9 117 0.5× 25 0.2× 45 0.4× 33 0.6× 42 1.1× 45 268

Countries citing papers authored by Marine Andreani

Since Specialization
Citations

This map shows the geographic impact of Marine Andreani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Andreani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Andreani more than expected).

Fields of papers citing papers by Marine Andreani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Andreani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Andreani. The network helps show where Marine Andreani may publish in the future.

Co-authorship network of co-authors of Marine Andreani

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Andreani. A scholar is included among the top collaborators of Marine Andreani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Andreani. Marine Andreani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gérard, Alexandre O., Alexandre Destère, Delphine Borchiellini, et al.. (2025). PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database. Frontiers in Immunology. 16. 1514033–1514033. 2 indexed citations
2.
Delaye, Matthieu, et al.. (2022). Onco-nephrology: Physicians’ Expectations About a New Subspecialty. Journal of Cancer Education. 38(3). 878–884. 2 indexed citations
3.
Gérard, Alexandre O., Susana Barbosa, Nadège Parassol, et al.. (2022). Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study. Clinical Kidney Journal. 15(10). 1881–1887. 13 indexed citations
4.
Gérard, Alexandre O., Marion Crémoni, Marine Andreani, et al.. (2022). Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety Database. Kidney International Reports. 7(7). 1699–1702. 1 indexed citations
5.
Gérard, Alexandre O., Marine Andreani, Nadège Parassol, et al.. (2021). Immune checkpoint inhibitors-induced nephropathy: a French national survey. Cancer Immunology Immunotherapy. 70(11). 3357–3364. 11 indexed citations
6.
Boyer‐Suavet, Sonia, Marine Andreani, Vesna Brglez, et al.. (2020). Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab. Frontiers in Immunology. 10. 3069–3069. 74 indexed citations
7.
Crémoni, Marion, Vesna Brglez, Sandra Pérez, et al.. (2020). Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses. Frontiers in Immunology. 11. 574997–574997. 42 indexed citations
8.
Cardot‐Leccia, Nathalie, Élodie Long-Mira, Marine Andreani, et al.. (2020). Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide. Journal of the European Academy of Dermatology and Venereology. 35(2). 1 indexed citations
9.
Seitz‐Polski, Barbara, Karine Dahan, Hanna Dêbiec, et al.. (2019). High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 14(8). 1173–1182. 92 indexed citations
10.
Andreani, Marine, Laetitia Albano, Sylvia Benzaken, et al.. (2019). Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R−): A Case Series. Transplantation Proceedings. 52(1). 204–211. 12 indexed citations
11.
Boyer‐Suavet, Sonia, Marine Andreani, Marion Crémoni, et al.. (2019). Rituximab bioavailability in primary membranous nephropathy. Nephrology Dialysis Transplantation. 34(8). 1423–1425. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026